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Anthropometric predictors of dyslipidemia 
among adults in Saudi Arabia
Abdalla A Saeed(1)
Background: dyslipidemia and obesity are key independent modifiable risk factors for many 
non communicable chronic diseases. Patterns of association between these factors may help 
prevention and control. This study aims to assess the association between lipids profile and 
obesity among adults in kingdom of Saudi arabia and identify anthropometric predictors of 
dyslipidemia.
MeThodS: data were collected and analyzed from a cross-sectional study using Who STePwise 
approach that included 4 990 Saudi adults aged 15- 64 years selected by stratified, multistage, cluster 
random sampling technique. Lipid profiles (cholesterol categories and triglycerides) were determined 
spectrophotometrically by colorimetric biochemical methods. obesity was determined by calculation 
of body mass index (BMI=kg/m2), waist and hip circumferences and ratio and waist to height ratio.
reSuLTS: the overall prevalence of obesity ranged from 33.8 to 44.4 % and the overall dyslipidemia 
prevalence ranged from about 25 to 44% depending on type of dyslipidemia and anthropometrics 
used. Prevalence of dyslipidemia and mean concentration of lipids profile were generally significantly 
higher in obese than non obese. The indicator waist/height ratio was the significant predictor for all 
types of dyslipidemia and all levels of serum lipids. 
concLuSIonS: the prevalence dyslipidemia and obesity are high and they are positively associated. 
Waist/height ratio was the most important predictor of dyslipidemia among adults.
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InTroducTIon
Obesity is a complex, multi-factorial, chronic 
condition that is associated with mortality and 
significant morbidity and is prevalent worldwide 
[1-3]. Studies in the Kingdom of Saudi Arabia 
(KSA) and other Gulf countries have highlighted 
the increasing burden of the reported 13–50% 
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prevalence of overweight and obesity in adults 
[4-9]. This pattern is comparable to other countries 
that have witnessed significant economic growth, 
resulting in a rise in obesity and obesity-related 
diseases [10]. Dyslipidemias are disorders of 
lipoprotein metabolism, including lipoprotein 
overproduction and deficiency. They may 
manifest as elevated total cholesterol (TC), high 
low-density lipoprotein cholesterol (LDL), and 
low high-density lipoprotein cholesterol (HDL) 
levels. Most triglyceride (TG) levels are considered 
atherogenic [11]. There is a general increasing 
trend in dyslipidemia with increasing obesity, in 
both males and females, in many communities 
[12-19]. In response to the increasing burden of 
obesity in KSA, an Obesity Chair was established 
to sponsor research and interventions designed 
to prevent and treat overweight and obesity 
[20]. The World Health Organization (WHO) 
Regional Office for the Eastern Mediterranean 
(EMRO) reviewed and discussed national 
and regional plans for the establishment of 
guidelines on dyslipidemia, obesity, and diabetes 
primary prevention and care [21]. Both obesity 
and dyslipidemia appear to develop from an 
interaction of genotype and the environment. 
This interaction involves the integration of social, 
behavioral, cultural, physiological, metabolic, 
and genetic factors. Using simple, noninvasive, 
anthropometric methods, diagnosing obesity as a 
possible predictor of dyslipidemia is expected to 
be helpful in efforts to prevent, diagnose early, 
and control both morbidities. This study aims to 
study anthropometric predictors of dyslipidemia. 
MeThodS
This is a cross-sectional, community-based 
study covering the whole population of KSA in 
2005. The WHO STEPwise approach to Surveillance 
(STEPS) of Non-Communicable Diseases (NCD) 
risk factors was the basis for conducting the survey 
and for collecting the data [22, 23].
The STEPS approach focuses on obtaining 
core data on the established risk factors that 
determine the major disease burden. It is 
sufficiently flexible to allow each country to 
expand on the core variables and risk factors, 
and to incorporate optional modules related to 
local or regional interests. The STEPS instrument 
covers three different levels of “steps” of risk 





All Saudi population aged 15–64 years 
from all the 20 health regions of the country 
comprised the study population. 
Sampling
A multistage stratified cluster random 
sampling technique was used to recruit the study 
subjects. Stratification was based on age (five 
10-year age groups) and gender (male/female, 
two groups). All health regions of the country (20 
regions) were covered. Based upon the proposed 
methodology of the WHO STEPwise approach, 
a sample size of 196 was calculated for each of 
these ten strata. A list of all Primary Health Care 
Centers (PHCCs) in each region was prepared; 
10% of these PHCCs were randomly chosen and 
allocated a regional sample proportionate to the 
size of their catchment population in sampled 
PHCCs. To identify the households, a map of the 
health center coverage area was used to choose 
the houses. Each house was assigned a number, 
and a simple random draw was made. 
data collection
Data were collected using the WHO 
STEPwise approach [22, 23], which included 
a questionnaire, physical and anthropometric 
measurements, biochemical measurements 
including serum lipids, chronic diseases, and 
risk factors. The questionnaire was translated 
into Arabic by a team of physicians and then 
back-translated to ensure the accuracy of the 
translation. The Arabic instrument was pre-tested 
and corrected before using it on 51 eligible 
respondents for wording and understanding of 
the questions. Necessary adjustments were made 
to the instrument in light of the pre-test. 
data collectors
Data were collected by 54 male and 54 
female collectors who worked in teams. Each 
field team was made up of four persons: a male 
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data collector, a female data collector, a driver, 
and a female assistant. Data collection teams were 
supervised by a hierarchy of a local supervisor, 
regional coordinators, and a national coordinator.
Training of data collectors
All individuals involved in data collection 
attended a comprehensive training workshop that 
included interview techniques, data collection 
tools, practical applications, and field guidelines.
analytical techniques
Blood (5 ml) was collected in the morning, 
after the participants had abstained from 
eating overnight. Sodium heparin was used 
as an anticoagulant, and the samples were 
centrifuged at 3 000 × g for 15 min at 20°C 
to separate plasma. Aliquots were prepared 
for storage (−20°C or −80°C) until further 
analysis. Total cholesterol (TC), triglycerides, 
and glucose were measured with commercially 
available enzymatic colorimetric kits from 
QCA (Amposta, Spain). Seriscann Normal 
(ref 994148) (QCA, Amposta, Spain) was 
used for quality control measures. Serum 
high-density lipoprotein cholesterol (HDL-
C) levels were analyzed by the enzymatic 
method after precipitating serum reagents with 
phosphotungstic acid and magnesium. LDL-
cholesterol (LDL-C) was calculated according 
to the Friedewald formula (LDL cholesterol = 
total cholesterol - HDL - (TG/5)) [24]. The cutoff 
levels used were according to the suggestions 
of the National Cholesterol Education Program–
Adult Treatment Panel III [25]. Dyslipidemia 
was defined as any hypercholesterolemia: 
total cholesterol concentration ≥5.2 mmol/L; 
hypertriglyceridemia with triglyceride 
concentration ≥1.27 mmol/L; low high-density 
lipoprotein-cholesterol (HDL-C) concentration 
≤0.90 mmol/L; or high low-density lipoprotein-
cholesterol (LDL-C) concentration ≥3.5 mmol/L. 
Height, weight, and waist and hip circumferences 
were measured using standard instruments, according 
to the STEPwise approach [22, 23].
anthropometric measurements
Body weight and height were measured 
without shoes, using an electronic measuring 
scale. Body mass index (BMI) was calculated 
as weight in kg divided by height in m2. Waist 
circumference (WC) was measured, in cm, 
midway between the lower costal margin and 
iliac crest during the end-expiratory phase. 
Hip circumference (HC) was measured, in 
cm, at the level of the greater trochanters. 
The waist-to-hip ratio (WHR) was defined as 
the waist circumference divided by the hip 
circumference, while the waist/height (WHtR) 
ratio was defined as the waist circumference 
divided by the height in cm. The cutoff levels 
for obesity are as follows, according to WHO 
and USA standards [22, 23, 26]:
BMI  30+
WHtR  0.5+
WHR  0.90+ for males 
  0.85 for females,
  excluding pregnant women
WC  102+ cm for males
  88+ cm for females,
  excluding pregnant women
data management
Questionnaires collected from the field 
were reviewed by the team leaders assigned 
to each team before submitting them to 
headquarters for data entry. Double entry of the 
questionnaires was performed using EPI-INFO 
2000 software and EpiData software developed 
by the Menzes Center for validation. After 
data entry, data cleaning was conducted. New 
variables were defined by adopting the standard 
STEPS variables (STEPS Data Management 
Manual, draft version v1.5, October 2003). 
Statistical analysis
The statistical analysis was performed 
using SPSS for Windows, version 17.0. The data 
were given as mean ± standard deviation for 
continuous variable and as counts and percentage 
for categorical variables. Association between 
categorical variables was assessed using a chi-
square test, and ANOVA was used to compare 
means of more than two categorical variables. 
Logistic regression was used to investigate the 
associations of the binary dependent variable 
“dyslipidemia” with the independent “obesity” 
anthropometric measurement variable. Multiple 
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linear regression analysis was performed to 
identify significant predictors for serum lipids 
levels. Level of significance was set at <0.05 
throughout the study. The data were processed 
using SPSS version 17. Totals counts may vary, 
due to missing data from certain variables.
ethical clearance and confidentiality
The protocol and the survey instrument were 
approved by the Ministry of Health, Center of 
Biomedical Ethics, and the appropriate authorities 
in KSA. Informed consent of all subjects was 
obtained. Confidentiality of data was assured, and 
that data will be used only for the stated purpose 
of the survey. The survey was conducted in 2005.
reSuLTS 
Of the 4 990 subjects included in the 
survey, about 5% (232 subjects) were excluded 
from final analysis, due to major deficiencies in 
their data. There were no significant differences 
between them and the rest of the 4 758 subjects 
regarding sociodemographic characteristics or 
obesity status. Table 1 shows age and gender 
distribution and prevalence of dyslipidemia 
types according to obesity status as measured 
by body mass index. About 51% of subjects 
were females; 23% were less than 25 years of 
age, and 11% were 55 or more years of age. 
Dyslipidemia prevalence ranged from about 
47% for TG in obese subjects to about 12% for 
TC among non-obese subjects. Dyslipidemia 
was higher in males than females and generally 
increasing significantly with age for all types. 
Table 2 shows the prevalence of obesity 
according to the different anthropometric 
measurements used. Obesity prevalence ranged 
from 33.8% as measured by WHtR to 40.4% as 
measured by WHR. Obesity was significantly 
higher in females than males, except for obesity 
measured by WHtR, which was significantly 
higher in males. Table 3 shows prevalence 
of types of dyslipidemia according to obesity 
measured by WHR, WHtR, and WC. Prevalence 
of all types of dyslipidemia was significantly 
higher among obese subjects, except for HDL 
dyslipidemia. Table 4 shows that only WHtR 
was the significant predictor of prevalence 
for all types of dyslipidemia, as revealed 
by the multiple logistic regression analysis. 
Table 5 shows that the mean concentration 
of all lipids profiles was higher in obese 
compared to non-obese subjects as measured 
by all anthropometric measurements. These 
differences were significant, except for obesity 
measured by WC for HDL, and measured by 
WHR except for TG. 
Waist for height ratio and Waist circumference 
were  significant predictors of almost all types 
of serum lipid concentration, as shown by the 
linear regression analysis in Table 6.
dIScuSSIon
Obesity is associated with endothelial 
dysfunction and greater arterial stiffness from 
as early as the first decade of life. This effect on 
vascular function is probably mediated in part by 
low-grade inflammation, insulin resistance, and 
production by adipose tissue of cytokine-like 
molecules, collectively termed adipokines and high 
leptin concentration [27]. Detecting obesity early 
by simple and reliable methods can help reverse 
or reduce these effects. Anthropometric indices, as 
used in this study, are surrogate measures of body 
fat. They require no sophisticated equipment or 
lengthy procedures. They are easy to measure and 
use, and they are cost-free. Obesity prevalence as 
assessed by all anthropometric measurements in 
this study was high, affecting 34–40% of the adult 
population, and confirming the findings of previous 
studies [4-6]. The results of this study showed that, 
in general, anthropometric measures of obesity 
were significantly correlated with prevalence 
of dyslipidemia. This finding is in agreement 
with many national, regional, and international 
studies [8-19, 28-35]. These studies, including the 
present study, however, have reported differential 
association of anthropometric measurements of 
obesity and prevalence of dyslipidemia type. 
This study revealed that all dyslipidemia types 
were significantly associated with obesity, except 
HDL. Lipid profile concentration for HDL was not 
significantly associated with obesity as measured 
by WC, and TG concentration was not significantly 
associated with obesity as measured by WHR. 
Only obesity as measured by WHtR was the 
significant predictor for prevalence of all types 
of dyslipidemia and lipid profile concentrations. 
Different anthropometric measures may be 
better predictors of dyslipidemia, according to 
populations studied. Significant predictors for 
dyslipidemia included BMI in a Sudanese study 
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Lipid profiLe         Gender   n (%) AGe in yeAr’S    n (%) 
Male  
2 340 (49.2)
FeMale   
2 418 (50.8)
< 25
1 076 (22.6)  
25 - < 35
1 130 (23.7)
35 - < 45 
 1 167 (24.5)
45 - < 55  
841 (17.7)
55+  




































































































































a=Total cholesterol, b=High density lipoprotein, c=Triglycerides , d=Low density lipoprotein, 
e=a/b ratio
*P value using chi square test
TaBle 1
Prevalence oF dysliPideMia according To oBesiTy sTaTus
(Measured By Body Mass index), gender and age oF suBjecTs
oBesiTy Male n (%) FeMale n (%) ToTal n (%) *P value
Body Mass Index ≥30 640 (28.6) 1 017 (43.4) 1 657 ( 36.1) <0.001
Waist for Hip ratio
Males ≥0.9, Females ≥0.85 1 092 (48.2) 688 (32.1) 1 780 (40.4) <0.001
Waist Circumference
Males≥102 cm, Females≥88 cm 602 (26.6) 912 (42.2) 1 514 (34.2) <0.001
Waist for Height ratio≥0.5 718 (32.0) 764 (35.6) 1 482 (33.8) 0.008
*P value using chi square test
TaBle 2
Prevalence oF oBesiTy using anThroPoMeTric MeasureMenTs according To gender
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[32], WC in Greek and Canadian studies [36, 
37], and WHR appeared to be the most suitable 
predictor of dyslipidemia in a study among Arabs 
and Asians in Kuwait [38]. Therefore, it appears that 
the best anthropometric index varies according to 
study design, geographic area, characteristics of 
the study population, and the outcome assessed. 
Higher prevalence of dyslipidemia, except HDL, 
was significantly associated with higher BMI in 
this study. Logistic regression analysis, however, 
showed that BMI was not a significant predictor 
for dyslipidemia prevalence. Body mass index 
was not significantly associated dyslipidemia in 
some studies [39, 40], and decreasing dyslipidemia 
prevalence was observed with increasing BMI 
in another study, which was difficult to explain 
[41]. Body mass index is the most common 
indicator used for obesity; it does not reflect 
body fat distribution or distinguish between the 
accumulations of lean or fat mass. In addition, 
BMI is less sensitive to changes in lifestyle patterns 
than measures of abdominal obesity. Reduction 
of calorie intake and increased physical activity 
cause a reduction of body fat, paralleled by an 
increase in muscle mass, resulting in marked 
changes in measures of abdominal obesity, but 
no or little change in BMI [42, 43]. Multiple 
studies have recently attempted to compare BMI 
with other anthropometric measures of obesity. 
The findings of the present study agree with 
the evidence that abdominal fat is a stronger 
predictor of blood lipids than overall body size 
as measured by BMI, as abdominal adiposity can 













































































































a=Total cholesterol, b=High density lipoprotein, c=Triglycerides , d=Low density lipoprotein, 
e=a/b ratio
*P value using chi square test
TaBle 3
Prevalence oF dysliPideMia according To anThroPoMeTric MeasureMenTs n (%) 
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obesity indices comparing BMI, WC, WHR, and 
WHtR, researchers concluded that WHtR was 
the best predictor for dyslipidemia for both men 
and women, while BMI was the least accurate 
[44]. Statistical evidence supports the superiority 
of measures of centralized obesity over BMI 
for detecting cardiovascular risk factors in both 
men and women [45]. This study showed that 
almost all obesity measures were significantly 
associated with dyslipidemia prevalence. Only 
waist circumference and WHtR were significant 
predictors for all types of dyslipidemia prevalence 
and all lipid concentrations. Our finding that 
WHtR was the only predictor for all dyslipidemia 
types agrees with the findings of several cross-
sectional studies that have shown that WHtR 
TaBle 4
MulTiPle logisTic regression analysis For anThroPoMeTric PredicTors oF dysliPideMia
anThroPoMeTrics/liPids
regression resulT
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best indicates the presence of cardiovascular risk 
factors, such as dyslipidemia [46, 47]. The WHtR 
was found to be significantly better than WC for 
indicating diabetes, hypertension, CVD, and all 
outcomes (P<0.005) among adults. There is robust 
statistical evidence from studies involving more 
than 300 000 adults in several ethnic groups, 
showing the superiority of WHtR over WC and 
BMI for detecting cardiometabolic risk factors 
in both sexes. The WHtR may be a more useful 
global clinical screening indicator for many other 
chronic diseases, such as diabetes mellitus and 
hypertension, supporting the simple public health 
message “Keep your waist circumference to less 
than half your height” [48]. The results of recent 
studies encourage the use of WHtR by General 
Practioners as an important tool in predicting 
CV risk [49], but its use for clinical decisions 
needs further study and robust evidence. The 
message from this study is that WHtR is the 
best anthropometric indicator to be used among 
adults in KSA. It can be utilized in all health care 
facilities, particularly PHCCs, for initial screening 
for dyslipidemia and other chronic diseases. The 
necessary equipment is available in these facilities, 
and all nurses and nutrition technicians are trained 
to measure WHtR.
Study limitations
This study is cross-sectional in nature; 
therefore, all the limitations of such studies 
are expected to have their effects. The causal 
association and the definite prediction of 
dyslipidemia by anthropometric measurements 
may be questionable. The study population 




























































































a=Total cholesterol, b=High density lipoprotein, c=Triglycerides, d=Low density lipoprotein, 
e=a/b ratio, (F)M(Sd): Mean concentration in millimoles per liter (Standard deviation)
*P value using aNOVa
TaBle 5
Mean concenTraTion (MMol/l) oF liPid ProFile according To anThroPoMeTric MeasureMenTs
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STEPwise protocol. In addition, the results may 
have been confounded by other factors, such 
as medication, nutrition, lifestyle habits, and 
chronic comorbidity.
concLuSIonS
This study revealed that dyslipidemia is 
prevalent among adults in KSA, is higher 
in males, significantly increases with age, 
and is significantly associated with obesity. 
Body mass index was not a predictor for 
any type of dyslipidemia. Waist/height ratio 
was the significant predictor for all types of 
dyslipidemias, and its use is recommended 
for screening and followup of dyslipidemic 
patients. It is easy, inexpensive, and can be 
used by all health team members, as well as 
other persons, with minimal training.
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a=Total cholesterol, b=High density lipoprotein, c=Triglycerides, d=Low density lipoprotein, e=a/b ratio
TaBle 6
linear regression analysis oF anThroPoMeTric PredicTors oF liPid levels (MMol/l) (P value) 
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